[Pharmacologic properties of several derivatives of 2-methyl-3-carboxy-4,5,6,7-tetrahydroindole].
D000818:Animals; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D055598:Chemical Phenomena; D002621:Chemistry; D002800:Cholinesterase Inhibitors; D002838:Chromaffin System / Q000187:drug effects*; D003594:Cytoplasmic Granules / Q000187:drug effects; D004298:Dopamine / Q000378:metabolism; D004759:Enterochromaffin Cells / Q000187:drug effects* / Q000648:ultrastructure; D007211:Indoles / Q000494:pharmacology*; D008297:Male; D008996:Monoamine Oxidase Inhibitors; D009638:Norepinephrine / Q000378:metabolism; D051381:Rats; D013329:Structure-Activity Relationship
D002800:Cholinesterase Inhibitors; D007211:Indoles; D008996:Monoamine Oxidase Inhibitors; D004298:Dopamine; D009638:Norepinephrine
Farmakologicheskie svoĭstva nekotorykh proizvodnykh 2-metil-3-karboksi-4,5,6,7-tetragidroindola